UBS(L)Eq.SICAV Ch.H.C(USD)UX a.USD/ LU2389359030 /
| NAV5/30/2024 | Chg.-32.2598 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 7,598.5400USD | -0.42% | reinvestment | Equity Sector Health / Pharma | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | - | - | - | - | - | - | - | - | -15.44 | -7.01 | 23.34 | 7.13 | - |
| 2023 | 10.72 | -9.44 | -3.90 | 0.33 | -7.72 | -2.24 | 5.04 | -5.19 | 1.21 | 3.26 | 2.62 | -5.12 | -11.61% |
| 2024 | -14.46 | 7.71 | -6.42 | 0.92 | -2.16 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.40% | 20.03% | 20.70% | -% | -% |
| Sharpe ratio | -1.78 | -1.94 | -1.01 | - | - |
| Best month | +7.71% | +7.71% | +7.71% | - | - |
| Worst month | -14.46% | -14.46% | -14.46% | - | - |
| Maximum loss | -17.05% | -22.36% | -23.26% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(L)Eq.SICAV Ch.H.C(USD)Q a.US... | reinvestment | 58.7500 | -18.27% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)P a.US... | reinvestment | 57.5100 | -18.95% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)UX a.U... | reinvestment | 7,598.5400 | -17.17% | - |
Performance
| YTD | -14.88% | ||
|---|---|---|---|
| 6 Months | -19.23% | ||
| 1 Year | -17.17% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -23.68% | ||
| Year | |||
| 2023 | -11.61% | ||
